JS InnoPharm Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Series B

  • Investors
  • 9

JS InnoPharm General Information

Description

Provider of outsourcing services intended to research and develop new drugs. The company provides new drug discovery services including molecular drug design, drug synthesis,in vivo and in vitro biological activity evaluation, and ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) testing, enabling medical institutions to promote the discovery of small molecule tumor immune drugs and oncology drugs.

Contact Information

Website
www.jsinnopharm.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 203 Building 1
  • No 1199 Landian Road, Pudong District
  • Shanghai
  • China
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Room 203 Building 1
  • No 1199 Landian Road, Pudong District
  • Shanghai
  • China

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

JS InnoPharm Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series B) 15-Nov-2021 Completed Clinical Trials - Phase 2
2. Later Stage VC (Series A1) 15-Jun-2020 Completed Generating Revenue
1. Later Stage VC (Series A) 01-Jan-2018 Completed Generating Revenue
To view JS InnoPharm’s complete valuation and funding history, request access »

JS InnoPharm Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

JS InnoPharm Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Baidu Ventures Corporate Venture Capital Minority
Hangzhou Tigermed Consulting Company Corporation Minority
Jiuyou Capital Venture Capital Minority
Shenzhen Qianhai Beizeng PE/Buyout Minority
Ming Bioventures Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

JS InnoPharm FAQs

  • When was JS InnoPharm founded?

    JS InnoPharm was founded in 2010.

  • Where is JS InnoPharm headquartered?

    JS InnoPharm is headquartered in Shanghai, China.

  • What is the size of JS InnoPharm?

    JS InnoPharm has 20 total employees.

  • What industry is JS InnoPharm in?

    JS InnoPharm’s primary industry is Drug Discovery.

  • Is JS InnoPharm a private or public company?

    JS InnoPharm is a Private company.

  • What is JS InnoPharm’s current revenue?

    The current revenue for JS InnoPharm is .

  • How much funding has JS InnoPharm raised over time?

    JS InnoPharm has raised $14.1M.

  • Who are JS InnoPharm’s investors?

    Baidu Ventures, Hangzhou Tigermed Consulting Company, Jiuyou Capital, Shenzhen Qianhai Beizeng, and Ming Bioventures are 5 of 9 investors who have invested in JS InnoPharm.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process